When most people think of lung cancer, smoking is usually the first cause that comes to mind. But surprisingly, up to 1 in 5 ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The province announced earlier this month it would allow uranium exploration in three areas. Most of those areas are on private land. The CBC's Frances Willick spoke with some of the affected property ...

Skolnik said, “For example, pulmonary function tests like spirometry are very helpful in gaining insight as to whether ...

The current situation in Bengal does not warrant alarm, but it does call for responsible, Covid-appropiate behaviour, say ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

Kolkata: Though there is no indication of any spike in Covid-19 cases in Bengal, multiple cases of the virus has surfaced ...

GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...

The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...

The FDA has granted approval to GSK's Nucala as an add-on maintenance treatment for adult patients suffering from inadequately controlled COPD.

GSK has received approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab).